How did Avon choose to partner with NCI instead of pharmaceutical companies or other industry partners?
Dr. Gomez: We have many credible programs, including SPOREs and cancer centers, which are well established and are embedded in various communities. These have proven to be very efficient programs and are recognized nationwide. The programs excel in their research and ability to carry out clinical interventions and were chosen for these reasons. I think we have demonstrated that we have an efficient system to receive, review, and disperse funds in a relatively short period of time of about 90 days. In addition, we have a proven system that is able to regulate and monitor clinical interventions. In particular, an organization such as Avon does not have to go through establishing an infrastructure that NCI has already built. We have proven programs like the SPORE program and the cancer centers program that are vetted in the community and have been proven to be very efficient at running clinical trials. Does NCI have other public-private partnerships similar to the NCI/Avon partnership in
Related Questions
- Aren Authorized Generics an effort by large pharmaceutical companies and their partners to circumvent the intent of the Hatch-Waxman Act which created the 180-day exclusivity period for the first generic drug approvals?
- Does STAT-A-MATRIX work with start-up companies as well as established organizations in the pharmaceutical industry?
- How did Avon choose to partner with NCI instead of pharmaceutical companies or other industry partners?
